The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
Primary Purpose
Knee Osteoarthritis
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
knee ultrasonography
Sponsored by
About this trial
This is an interventional screening trial for Knee Osteoarthritis focused on measuring knee osteoarthritis, type 2 diabetes
Eligibility Criteria
Inclusion Criteria:
- being female
- aged between 40 and 70.
Exclusion Criteria:
- Patients with any concomitant chronic disease
- rheumatoid arthritis
- cardiac diseases (except type 2 diabetes mellitus and hypertension)
- knee surgery
- trauma
- bone mass or cancer
- inflammatory arthritis
- impaired cognitive status
- immobilized patients
- type 1 diabetes mellitus
Sites / Locations
- Eskişehir City Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Patients with type 2 diabetes
Patients without type 2 diabetes
Arm Description
Patients with diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
Patients without diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
Outcomes
Primary Outcome Measures
Femoral cartilage thickness
Measured by ultrasonography (higher value:thick cartilage, lower value:thin cartilage)
Secondary Outcome Measures
visual analog scale
pain measurement (point 0 to 10) 0:worse pain 10:no pain
radiographic knee osteoarthritis
evaluated by kellgren lawrance scale.(0-4) 0:no osteoarthritis, 4: severe osteoarthritis
Full Information
NCT ID
NCT04779164
First Posted
February 25, 2021
Last Updated
February 27, 2021
Sponsor
Eskisehir City Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04779164
Brief Title
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
Official Title
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
September 4, 2020 (Actual)
Primary Completion Date
October 30, 2020 (Actual)
Study Completion Date
October 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Eskisehir City Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Background:Knee osteoarthritis is more common in patients with type-2 diabetes mellitus, however it is not known whether this effect is caused by diabetes itself or concominant abdominal obesity.
Objectives:The aim of this study is to determine whether type-2 diabetes itself, independent of abdominal obesity, is a risk factor for femoral cartilage, knee osteoarthritis and poor quality of life.
Design:A cross-sectional design. Settings:Training and research hospital in Turkey. Patients and Methods:Female patients was enrolled in this study and divided into two groups: according to presence or absence of diabetes. Later, both the patients with and without abdominal obesity was divided into two groups according the presence of diabetes.
Main Outcome measures:Clinical parameters were visual analog-scale, gait speed and short form-36. Knee radiographs were evaluated according to Kellgren Lawrance-Scale. And ultrasonography parameters were the measurements of distal femoral cartilage thickness.
Sample size:126
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
Keywords
knee osteoarthritis, type 2 diabetes
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Both patients with and without diabetes mellitus was evaluated in terms of pain and ultrasonographic femoral cartilage thickness.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
126 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patients with type 2 diabetes
Arm Type
Experimental
Arm Description
Patients with diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
Arm Title
Patients without type 2 diabetes
Arm Type
Other
Arm Description
Patients without diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
Intervention Type
Diagnostic Test
Intervention Name(s)
knee ultrasonography
Intervention Description
The knees of all patients were screened with ultrasonography device for the measurement of femoral cartilage thicknesses.
Primary Outcome Measure Information:
Title
Femoral cartilage thickness
Description
Measured by ultrasonography (higher value:thick cartilage, lower value:thin cartilage)
Time Frame
baseline
Secondary Outcome Measure Information:
Title
visual analog scale
Description
pain measurement (point 0 to 10) 0:worse pain 10:no pain
Time Frame
baseline
Title
radiographic knee osteoarthritis
Description
evaluated by kellgren lawrance scale.(0-4) 0:no osteoarthritis, 4: severe osteoarthritis
Time Frame
baseline
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Knee osteoarthritis is more common in women.
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
being female
aged between 40 and 70.
Exclusion Criteria:
Patients with any concomitant chronic disease
rheumatoid arthritis
cardiac diseases (except type 2 diabetes mellitus and hypertension)
knee surgery
trauma
bone mass or cancer
inflammatory arthritis
impaired cognitive status
immobilized patients
type 1 diabetes mellitus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fulya Bakılan
Organizational Affiliation
Eskisehir City Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Eskişehir City Hospital
City
Eskişehir
Country
Turkey
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
1 year later
Learn more about this trial
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
We'll reach out to this number within 24 hrs